← Back to headlines
Study Suggests GLP-1 Drugs May Reduce Breast Cancer Risk
A new study indicates that individuals using GLP-1 medications are 30% less likely to develop breast cancer, prompting experts to weigh in on the potential preventative benefits of these drugs.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
